These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25655720)

  • 1. (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.
    Andersen VL; Hansen HD; Herth MM; Dyssegaard A; Knudsen GM; Kristensen JL
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1053-6. PubMed ID: 25655720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimavanserin exhibits serotonin 5-HT
    Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
    Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral 5-HT release correlates with [
    Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin.
    Majlath Z; Obal I; Vecsei L
    CNS Neurol Disord Drug Targets; 2017; 16(3):234-243. PubMed ID: 27719624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergent
    Petersen IN; Villadsen J; Hansen HD; Jensen AA; Lehel S; Gillings N; Herth MM; Knudsen GM; Kristensen JL
    Bioorg Med Chem; 2016 Nov; 24(21):5353-5356. PubMed ID: 27624522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
    Jalal B
    Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors.
    Stahl SM
    CNS Spectr; 2016 Aug; 21(4):271-5. PubMed ID: 27503570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimavanserin.
    Hunter NS; Anderson KC; Cox A
    Drugs Today (Barc); 2015 Nov; 51(11):645-52. PubMed ID: 26744739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling and preliminary in vivo evaluation of the 5-HT(7) receptor selective agonist [(11)C]E-55888.
    Hansen HD; Andersen VL; Lehel S; Magnussen JH; Dyssegaard A; Stroth N; Kristensen JL; Knudsen GM; Herth MM
    Bioorg Med Chem Lett; 2015 May; 25(9):1901-4. PubMed ID: 25857944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.
    Yasue I; Matsunaga S; Kishi T; Fujita K; Iwata N
    J Alzheimers Dis; 2016; 50(3):733-40. PubMed ID: 26757194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, Molecular Docking, and Biological Evaluation of Novel Pimavanserin-Based Analogues as Potential Serotonin 5-HT
    Albujuq NR; Meana JJ; Diez-Alarcia R; Muneta-Arrate I; Naqvi A; Althumayri K; Alsehli M
    J Med Chem; 2023 Jul; 66(13):9057-9075. PubMed ID: 37378639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.
    Cummings J; Isaacson S; Mills R; Williams H; Chi-Burris K; Corbett A; Dhall R; Ballard C
    Lancet; 2014 Feb; 383(9916):533-40. PubMed ID: 24183563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.
    Ettrup A; da Cunha-Bang S; McMahon B; Lehel S; Dyssegaard A; Skibsted AW; Jørgensen LM; Hansen M; Baandrup AO; Bache S; Svarer C; Kristensen JL; Gillings N; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2014 Jul; 34(7):1188-96. PubMed ID: 24780897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
    McFarland K; Price DL; Bonhaus DW
    Behav Pharmacol; 2011 Oct; 22(7):681-92. PubMed ID: 21921840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimavanserin, a 5HT
    Yuede CM; Wallace CE; Davis TA; Gardiner WD; Hettinger JC; Edwards HM; Hendrix RD; Doherty BM; Yuede KM; Burstein ES; Cirrito JR
    J Neurochem; 2021 Mar; 156(5):658-673. PubMed ID: 33278025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.